2023 Generic Medicine Vaccines 
STAT
OCTOBER 10, 2023
The state’s biotech scene exploded in the mid-2010s and early in the pandemic as exuberant investors disregarded the high failure rate in drug development and bet on buzzy technologies such as gene editing and messenger RNA vaccines. But the drumbeat of layoffs in 2022 has only grown louder this year.
Express Pharma
NOVEMBER 15, 2024
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 12, 2024
In 2023, while the deal volume declined, the deal value grew (1), due to strategic megadeals in the pharma sector. Covid-19 promoted India to the centre stage of global vaccine export as the consumerisation of health providing an impetus for vaccines and prompt approvals. India’s pharmaceutical sector is on a growth trajectory.
Express Pharma
JUNE 21, 2024
In 2023, while the deal volume declined, the deal value grew1, due to strategic megadeals in the pharma sector. Covid-19 promoted India to the centre stage of global vaccines export as consumerisation of health providing an impetus for vaccines and prompt approvals. India’s pharmaceutical sector is on a growth trajectory.
Express Pharma
JULY 3, 2023
Many millions of people are vaccinated against COVID-19, thanks to a messenger RNA (mRNA) encapsulated within a lipid nanoparticle. With our joint announcement on June 4, 2023, Waters and Sartorius entered a new phase of our collaboration, this time to support downstream bioprocessing as well. How poised are you to leverage them?
Express Pharma
JUNE 15, 2024
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global generic medicines, along with 60 per cent of the total vaccine demand worldwide.
European Pharmaceutical Review
APRIL 3, 2023
It is the eighth vaccine recommended in the European Union (EU) for COVID-19. On 3 April 2023, the treatment was recommended by the CHMP for adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+).
Expert insights. Personalized for you.
317 
Let's personalize your content